$101.04 -1.34 (%) Johnson & Johnson - NYSE

Jan. 30, 2015 | 11:39 AM

Partner Headlines

  1. ETF Spotlight: Dividend Aristocrat Index

    Benzinga | Jan. 29, 2015 | 14:58PM EST
  2. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  3. Are ETFs and CEFs Good Dividend Growth Investments?

    GuruFocus | Jan. 27, 2015 | 16:15PM EST
  4. Will Johnson & Johnson Continue Soaring?

    GuruFocus | Jan. 25, 2015 | 23:16PM EST
  5. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  6. Johnson & Johnson's Strong Momentum Will Continue

    GuruFocus | Jan. 22, 2015 | 17:25PM EST
  7. Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth

    Benzinga | Jan. 22, 2015 | 11:54AM EST
  8. Covidien Q1 Earnings Beat Estimates As Buyout Nears

    IBD | Jan. 22, 2015 | 11:02AM EST
  9. Why Minerva Neurosciences Is Trading Higher

    Benzinga | Jan. 21, 2015 | 21:21PM EST
  10. Making Money With Charles Payne: 01/21/15

    FoxBusiness | Jan. 21, 2015 | 18:00PM EST
  11. Johnson and Johnson Beats Earnings Estimate, Slides On a Weak Outlook

    GuruFocus | Jan. 21, 2015 | 17:06PM EST
  12. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  13. ECB Easing Could Strengthen Headwinds For U.S. Firms

    Benzinga | Jan. 21, 2015 | 11:23AM EST
  14. Morgan Stanley Sees Balance Sheet & Pipeline As More Critical For Johnson & Johnson

    Benzinga | Jan. 21, 2015 | 07:54AM EST
  15. CNBC's Stock Pops & Drops From January 20

    Benzinga | Jan. 20, 2015 | 20:35PM EST
  16. J&J earnings beat, sales miss

    IBD | Jan. 20, 2015 | 18:45PM EST
  17. Making Money With Charles Payne: 01/20/15

    FoxBusiness | Jan. 20, 2015 | 18:00PM EST
  18. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  19. Stocks Quickly Give Up Early Gain; Airlines Follow Delta Higher

    IBD | Jan. 20, 2015 | 10:35AM EST
  20. Morning Market Losers

    Benzinga | Jan. 20, 2015 | 09:57AM EST
  21. UPDATE: Johnson & Johnson Posts Upbeat Q4 Earnings

    Benzinga | Jan. 20, 2015 | 08:41AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 20, 2015 | 08:24AM EST
  23. Johnson and Johnson Posts Mixed Fourth Quarter

    FoxBusiness | Jan. 20, 2015 | 07:52AM EST
  24. Earnings Scheduled For January 20, 2015

    Benzinga | Jan. 20, 2015 | 04:40AM EST
  25. 7 Stocks You Should Be Watching Today

    Benzinga | Jan. 20, 2015 | 04:01AM EST
  26. Depomed

    IBD | Jan. 16, 2015 | 18:35PM EST
  27. Stocks Cap Week With Losses; Super Micro Jumps

    IBD | Jan. 16, 2015 | 17:08PM EST
  28. Week Ahead: The ECB, Housing Data and Earnings

    FoxBusiness | Jan. 16, 2015 | 15:37PM EST
  29. Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher

    Benzinga | Jan. 16, 2015 | 15:36PM EST
  30. Depomed Hits High On Big Pain-Drug Deal With J&J

    IBD | Jan. 16, 2015 | 11:32AM EST
  31. Benzinga's Volume Movers

    Benzinga | Jan. 16, 2015 | 11:09AM EST
  32. Knuckman On Johnson & Johnson And Ford: Surprise Movers?

    Benzinga | Jan. 16, 2015 | 11:02AM EST
  33. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 16, 2015 | 10:34AM EST
  34. Morning Market Gainers

    Benzinga | Jan. 16, 2015 | 09:49AM EST
  35. Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals

    Benzinga | Jan. 16, 2015 | 08:58AM EST
  36. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 16, 2015 | 08:11AM EST
  37. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga | Jan. 15, 2015 | 17:40PM EST
  38. Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion

    Benzinga | Jan. 15, 2015 | 17:23PM EST
  39. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  40. Zeltiq, Stryker, St. Jude Move On Prelim Q4 Reports

    IBD | Jan. 14, 2015 | 12:48PM EST
  41. Wall Street's Wheelings And Dealings

    Benzinga | Jan. 13, 2015 | 14:49PM EST
  42. 9 High Rated, Lower Debt Dividend Stocks With A Reasonable Payout

    GuruFocus | Jan. 13, 2015 | 12:47PM EST
  43. Pharmacyclics Soars As Imbruvica Sales Beat Estimates

    IBD | Jan. 13, 2015 | 11:29AM EST
  44. Visa A Star Dividend Stock

    GuruFocus | Jan. 13, 2015 | 10:38AM EST
  45. J&J signs Alzheimer's accord

    IBD | Jan. 12, 2015 | 18:58PM EST
  46. Dividend Smart Stocks

    GuruFocus | Jan. 12, 2015 | 13:08PM EST
  47. What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

    Benzinga | Jan. 9, 2015 | 12:43PM EST
  48. 3 Sectors That Could Survive A Correction

    Benzinga | Jan. 7, 2015 | 08:11AM EST
  49. Healthcare Sector Survives Europe's Slide

    Benzinga | Jan. 6, 2015 | 15:58PM EST
  50. 2014 Results & Review of Largest Holdings

    GuruFocus | Jan. 6, 2015 | 11:26AM EST
Trading Center